Fragment-Based Drug Discovery

被引：2

作者：

Norton, Raymond S. ^{[1
]}

机构：

[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

来源：

关键词：

D O I：

10.1071/CH13492

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：1463 / 1464

页数：2

共 50 条

[1] Fragment-based drug discovery
Erlanson, DA
McDowell, RS
O'Brien, T
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) : 3463 - 3482
[2] Fragment-based drug discovery
Warr, Wendy A.
[J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (08) : 453 - 458
[3] Fragment-based drug discovery
Wendy A. Warr
[J]. Journal of Computer-Aided Molecular Design, 2009, 23 : 453 - 458
[4] Experiences in fragment-based drug discovery
Murray, Christopher W.
Verdonk, Marcel L.
Rees, David C.
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 224 - 232
[5] The rise of fragment-based drug discovery
Murray C.W.
Rees D.C.
[J]. Nature Chemistry, 2009, 1 (3) : 187 - 192
[6] Tethering: Fragment-based drug discovery
Erlanson, DA
Wells, JA
Braisted, AC
[J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 : 199 - 223
[7] Introduction to Fragment-Based Drug Discovery
Erlanson, Daniel A.
[J]. FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 1 - 32
[8] The rise of fragment-based drug discovery
Murray, Christopher W.
Rees, David C.
[J]. NATURE CHEMISTRY, 2009, 1 (03) : 187 - 192
[9] Fragonomics: fragment-based drug discovery
Zartler, ER
Shapiro, MJ
[J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (04) : 366 - 370
[10] Fragment-based drug discovery: Less is more
Heightman, Tom D.
[J]. CANCER RESEARCH, 2014, 74 (19)